CalciMedica Share Price

CalciMedica Share Price

NASDAQ: CALC | Micro Cap | Healthcare
$1.26
+$1.26 (--%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

CalciMedica Stock Performance

Open
$1.28
Prev. Close
N/A
Circuit Range
N/A
Day Range
$1.26 - $1.28
Year Range
$0.47 - $6.79
Volume
1,200
Average Traded
$1.26

CalciMedica Share Price Chart

Line chart of the CalciMedica price trend over the selected period. The price rose overall, ranging from 1.26 to 1.27, ending at 1.27.
$1.26$1.28
L
Show Current Price
H

CalciMedica Stock Fundamentals & Key Indicators

Market Cap
$18.91M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-2.19
Revenue (TTM)
$0.00
Return On Equity (TTM)
-357.46%
Profit Margin
N/A
Debt to Equity
1.63
Quarterly Earnings Growth YoY
84.48%

CalciMedica Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$10.76$4.98-$7.65-$1.67
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A146.28%-253.61%78.17%

CalciMedica Annual Profit & Loss

All figures in USD

Particulars202320242025
Revenue$0.00$0.00$0.00
Net Profit-$34.36-$13.70-$29.56
Net Profit MarginN/AN/AN/A
Income ChangeN/A60.13%-115.77%

CalciMedica Balance Sheet

All figures in USD Million

Particulars202520242023
Non Current Assets0.060.130.58
Current Assets13.5319.6711.61
Total Assets13.5919.7912.19
Non Current Liabilities16.451.70.0
Current Liabilities3.783.684.03
Total Liabilities20.235.384.03
Shareholders' Equity-6.6414.418.16

CalciMedica Cash Flow

Annually

All figures in USD Million

Particulars202520242023
Operating-21.18-21.15-25.73
Investing9.55-4.428.88
Financing15.2127.9720.9

Corporate Actions

Split
Ex-date: 31 Aug 2026

Split
Ex-date: 20 Mar 2023

About CalciMedica

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys. The company operates as one operating segment focused on developing and commercializing therapeutics in the U.S.

CalciMedica Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$1.48
$1.26
-27.17%
Oct 2026
$1.64
$1.73
+6.46%
Sep 2026
$2.13
$1.63
+247.22%
Aug 2026
$0.96
$0.47
-52.24%
Jul 2026
$0.98
$0.98
+0.20%
Jun 2026
$0.85
$0.98
+25.38%
May 2026
$0.61
$0.78
+36.84%
Apr 2026
$0.59
$0.57
+5.56%
Mar 2026
$0.49
$0.54
+4.25%
Feb 2026
$0.78
$0.52
-42.12%
Jan 2026
$6.63
$0.90
-86.56%
Dec 2025
$4.34
$6.66
+57.82%

CalciMedica Share Price FAQs